Unknown

Dataset Information

0

Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2.

ABSTRACT: T-regulatory cells (T(regs)) are a rare lymphocyte subtype that shows promise for treating infectious disease, allergy, graft-versus-host disease, autoimmunity, and asthma. Clinical applications of T(regs) have not been fully realized because standard methods of expansion ex vivo produce heterogeneous progeny consisting of mixed populations of CD4 + T cells. Heterogeneous progeny are risky for human clinical trials and face significant regulatory hurdles. With the goal of producing homogeneous T(regs), we developed a novel expansion protocol targeting tumor necrosis factor receptors (TNFR) on T(regs). In in vitro studies, a TNFR2 agonist was found superior to standard methods in proliferating human T(regs) into a phenotypically homogeneous population consisting of 14 cell surface markers. The TNFR2 agonist-expanded T(regs) also were functionally superior in suppressing a key T(reg) target cell, cytotoxic T-lymphocytes. Targeting the TNFR2 receptor during ex vivo expansion is a new means for producing homogeneous and potent human T(regs) for clinical opportunities.

SUBMITTER: Okubo Y 

PROVIDER: S-EPMC3818650 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2.

Okubo Yoshiaki Y   Mera Toshiyuki T   Wang Limei L   Faustman Denise L DL  

Scientific reports 20131106

T-regulatory cells (T(regs)) are a rare lymphocyte subtype that shows promise for treating infectious disease, allergy, graft-versus-host disease, autoimmunity, and asthma. Clinical applications of T(regs) have not been fully realized because standard methods of expansion ex vivo produce heterogeneous progeny consisting of mixed populations of CD4 + T cells. Heterogeneous progeny are risky for human clinical trials and face significant regulatory hurdles. With the goal of producing homogeneous T  ...[more]

Similar Datasets

Unknown Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2.
| S-EPMC7714153 | biostudies-literature
Unknown Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells.
| S-EPMC4000541 | biostudies-literature
Unknown Tumor necrosis factor receptor family costimulation increases regulatory T-cell activation and function via NF-κB.
| S-EPMC7383872 | biostudies-literature
Unknown Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant.
| S-EPMC2842000 | biostudies-literature
Unknown Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
| S-EPMC2043531 | biostudies-literature
Unknown Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
| S-EPMC2556620 | biostudies-literature
Unknown The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4<sup>+</sup>Foxp3<sup>+</sup> Regulatory T Cells.
| S-EPMC6046375 | biostudies-literature
Unknown Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.
| S-EPMC5529482 | biostudies-literature
Unknown RNPS1 inhibits excessive tumor necrosis factor/tumor necrosis factor receptor signaling to support hematopoiesis in mice.
| S-EPMC9170173 | biostudies-literature
Unknown Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy.
| S-EPMC4030310 | biostudies-literature